< Back to Bio
Icon close orange Eva A. Temkin

News 8 results

In the News · Source: The Center for Biosimilars

March 30, 2021
Eva Temkin discusses the chances that biosimilars will be developed for orphan drugs

In the News · Source: Politico, Bloomberg Law, The Daily Docket, IP Magazine, Law.com, Law360, Bloomberg Law, Generics Bulletin, Pharmalife, Endpoints News and The Washington Post

March 29, 2021
Eva Temkin, former Acting Director for Policy at the FDA’s Office of Therapeutic Biologics and Biosimilars, joins the firm’s FDA & Life Sciences team in the Washington, D.C., office

In the News · Source: The Center for Biosimilars

March 29, 2021
Eva Temkin addresses the changing regulatory landscape and public perceptions of biosimilars